+Compare
VVOS
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
5.06M

VVOS Vivos Therapeutics Forecast, Technical & Fundamental Analysis

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for VVOS with price predictions
07:00 PM EST Nov 27, 2023

VVOS saw its Stochastic Oscillator peaks and leaves the overbought zone

The Stochastic Oscillator for VVOS moved out of overbought territory on November 27, 2023. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 21 similar instances where the indicator exited the overbought zone. In of the 21 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

VVOS moved below its 50-day moving average on October 27, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for VVOS crossed bearishly below the 50-day moving average on October 30, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VVOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VVOS broke above its upper Bollinger Band on November 21, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VVOS entered a downward trend on November 22, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VVOS's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 14, 2023. You may want to consider a long position or call options on VVOS as a result. In of 45 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VVOS just turned positive on November 15, 2023. Looking at past instances where VVOS's MACD turned positive, the stock continued to rise in of 22 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VVOS advanced for three days, in of 130 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. VVOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (109.890) is normal, around the industry mean (25.167). P/E Ratio (0.014) is within average values for comparable stocks, (79.649). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.240). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (0.335) is also within normal values, averaging (45.457).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VVOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.4B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 3%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 703%. ICCM experienced the highest price growth at 85%, while SLDX experienced the biggest fall at -83%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was 47%. For the same stocks of the Industry, the average monthly volume growth was 49% and the average quarterly volume growth was 79%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 55
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -4 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published Earnings

VVOS is expected to report earnings to fall 35.43% to -112 cents per share on March 28

Vivos Therapeutics VVOS Stock Earnings Reports
Q4'23
Est.
$-1.13
Q3'23
Beat
by $1.38
Q2'23
Missed
by $0.01
Q1'23
Beat
by $0.11
Q4'22
Beat
by $0.03
The last earnings report on November 14 showed earnings per share of -175 cents, beating the estimate of -313 cents. With 15.11M shares outstanding, the current market capitalization sits at 5.06M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
7921 Southpark Plaza
Phone
+1 844 672-4357
Employees
163
Web
https://www.vivos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEHL2.520.21
+9.09%
Antelope Enterprise Holdings Limited
APYX2.970.03
+1.02%
Apyx Medical Corp
EBC12.04-0.04
-0.33%
Eastern Bankshares
CCK82.19-0.45
-0.54%
Crown Holdings
LWLG4.13-0.14
-3.28%
Lightwave Logic

VVOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VVOS has been loosely correlated with RSLS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VVOS jumps, then RSLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
+3.82%
RSLS - VVOS
40%
Loosely correlated
-7.38%
MBOT - VVOS
25%
Poorly correlated
-3.68%
INGN - VVOS
23%
Poorly correlated
-1.53%
OMIC - VVOS
23%
Poorly correlated
-4.42%
CORBF - VVOS
23%
Poorly correlated
-4.00%
More

Groups containing VVOS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
+3.82%
Medical Specialties
(undefined stocks)
12%
Poorly correlated
+1.11%
Medical Specialties
(undefined stocks)
12%
Poorly correlated
+1.11%